Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
PET CT Re-Planning NSCLC (4DCT-PET)
- Status
- COMPLETED
- Phase
- NA
First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
The Continuation of Gefitinib Treatment Beyond Progression in Non-small Cell Lung Cancer Patients With EGFR Mutation
- Status
- UNKNOWN
- Phase
- PHASE2
Study of LYC-55716 With Pembrolizumab in Adult Subjects With Non-Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
A Phase 2 Study of Osimertinib in Combination With Selumetinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin® in Advanced Non-squamous Non-small Cell Lung Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Pulmonary Physiology and Systemic Inflammatory in EO Pulmonary Events With Brigatinib Use in NSCLC and Other Diseases
- Status
- COMPLETED
- Phase
- N/A
BPI-7711 Capsule in Patients With EGFR Mutation T790M Positive Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Efficacy of Xalkori ROS1
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Prospective Study of Constructing Immune Repertoire to Monitor the Therapeutic Effect in NSCLC Patients
- Status
- UNKNOWN
- Phase
- N/A
Efficacy Study of Comprehensive Rehabilitation Program Plus Chemotherapy in Postoperative NSCLC Patients
- Status
- UNKNOWN
- Phase
- PHASE3
Isatuximab in Combination With REGN2810 (Cemiplimab) in Patients With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Haploidentical NK Cells After Pemetrexed in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1
Comparison of Efficacy and Safety of Tislelizumab (BGB-A317) Versus Docetaxel as Treatment in the Second- or Third-line Setting in Participants With Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE3
Explore Intra-tumor Heterogeneity and Prognostic Value of Postoperative Blood ctDNA of ⅡA - ⅢA Stage Non-squamous NSCLC Based on the Capture-based Sequencing and UMI Technology of Burning Rock
- Status
- UNKNOWN
- Phase
- N/A
Phase II Umbrella Study of Novel Anti-cancer Agents in Participants With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2